Want to join the conversation?
$LLY, the maker of insulin Humalog, said that in 4Q15 it received approval for launching Portrazza, a lung cancer drug, in US. The company terminated basal insulin peglispro, a treatment for type 1 and type 2 diabetes. $LLY expanded its R&D facility in Indianapolis and announced the closure of animal health manufacturing facility in Sligo, Ireland.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.